Literature DB >> 30363531

Low-Frequency Stimulation of Globus Pallidus Internus for Axial Motor Symptoms of Parkinson's Disease.

Maurizio Zibetti1, Andres M Lozano2, Marina Picillo3,4, Renato P Munhoz3, Alfonso Fasano3.   

Abstract

Entities:  

Keywords:  Parkinson's disease; deep brain stimulation; low frequency

Year:  2015        PMID： 30363531      PMCID： PMC6178598          DOI： 10.1002/mdc3.12215

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN： 2330-1619


× No keyword cloud information.
  6 in total

1.  A meta-regression of the long-term effects of deep brain stimulation on balance and gait in PD.

Authors:  R J St George; J G Nutt; K J Burchiel; F B Horak
Journal:  Neurology       Date:  2010-10-05       Impact factor: 9.910

2.  Lower stimulation frequency can enhance tolerability and efficacy of pallidal deep brain stimulation for dystonia.

Authors:  Ron L Alterman; Jay L Shils; Joan Miravite; Michele Tagliati
Journal:  Mov Disord       Date:  2007-02-15       Impact factor: 10.338

3.  Low-frequency subthalamic nucleus stimulation in Parkinson's disease.

Authors:  Christos Sidiropoulos; Elena Moro
Journal:  Mov Disord       Date:  2014-07-02       Impact factor: 10.338

Review 4.  Axial disability and deep brain stimulation in patients with Parkinson disease.

Authors:  Alfonso Fasano; Camila C Aquino; Joachim K Krauss; Christopher R Honey; Bastiaan R Bloem
Journal:  Nat Rev Neurol       Date:  2015-01-13       Impact factor: 42.937

5.  GPi-DBS in Huntington's disease: results on motor function and cognition in a 72-year-old case.

Authors:  Alfonso Fasano; Paolo Mazzone; Carla Piano; Davide Quaranta; Francesco Soleti; Anna Rita Bentivoglio
Journal:  Mov Disord       Date:  2008-07-15       Impact factor: 10.338

6.  Selective use of low frequency stimulation in Parkinson's disease based on absence of tremor.

Authors:  Elizabeth L Stegemöller; Srikant Vallabhajosula; Ihtsham Haq; Nelson Hwynn; Chris J Hass; Michael S Okun
Journal:  NeuroRehabilitation       Date:  2013       Impact factor: 2.138
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.